—For patients with severe obstructive sleep apnea that doesn’t respond to traditional treatments, hypoglossal nerve stimulation may be an option. But as a new study highlights, screening for eligible ...

In recent days, Inspire Medical Systems has been hit by Medicare contractors Noridian and CGS unexpectedly removing CPT code 64568 for hypoglossal nerve stimulation, forcing providers toward an ...

Targeted hypoglossal nerve stimulation (THN) showed safety and efficacy for patients with moderate-to-severe obstructive sleep apnea (OSA), the randomized THN3 trial found. Four months after receiving ...

While Obstructive Sleep Apnea (OSA) affects about five percent of the general pediatric population, 80 percent of children with Down syndrome experience OSA. Continual OSA results in poor health, ...

To qualify for the device, called a hypoglossal nerve stimulator, a person over 18 diagnosed with moderate-to-severe obstructive sleep apnea must be unable to adapt or refuse to wear a continuous ...

Nyxoah ( ($NYXH) ) has issued an update. On December 17, 2025, Nyxoah announced the commercial launch of its Genio hypoglossal neurostimulation ...

Upper airway hypoglossal nerve stimulation is safe and effective in adolescents with Down syndrome and severe persistent obstructive sleep apnea (OSA) occurring after adenotonsillectomy, and who ...

Medicare coverage does not necessarily mean appropriate reimbursement levels, a point pressed by Inspire Medical Systems Inc. at the Aug. 23 Medicare outpatient advisory panel hearing. The panel ...

Christopher Hartnick, MD, MS, director of the Division of Pediatric Otolaryngology at Mass Eye and Ear, is the senior and corresponding author and Brian Skotko, MD, MPP, the director of the Down ...

Christopher Hartnick, MD, MS, director of the Division of Pediatric Otolaryngology at Mass Eye and Ear, is the senior and corresponding author and Brian Skotko, MD, MPP, the director of the Down ...

Medicare coverage does not necessarily mean appropriate reimbursement levels, a point pressed by Inspire Medical Systems Inc. at the Aug. 23 Medicare outpatient advisory panel hearing. The panel ...